Caryn Peterson's most recent trade in Gossamer Bio Inc was a trade of 440,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 440,000 | 440,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 18 Mar 2024 | 4,018 | 49,833 (0%) | 0% | 1.3 | 5,343 | Common Stock |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 375,000 | 375,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 190,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 126,667 | 126,667 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 48,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 34,175 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 32,334 | 32,334 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 31,750 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 28,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 22,784 | 22,784 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 21,167 | 21,167 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 18,834 | 18,834 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 13,750 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 9,167 | 9,167 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 157,500 | 157,500 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 16 Mar 2023 | 7,564 | 53,851 (0%) | 0% | 1.1 | 8,305 | Common Stock |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Sale of securities on an exchange or to another person at price $ 12.07 per share. | 24 Oct 2022 | 4,757 | 61,415 (0%) | 0% | 12.1 | 57,431 | Common Stock |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Sale of securities on an exchange or to another person at price $ 8.28 per share. | 16 Mar 2022 | 6,279 | 66,172 (0%) | 0% | 8.3 | 51,978 | Common Stock |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Sale of securities on an exchange or to another person at price $ 12.25 per share. | 25 Oct 2021 | 2,377 | 72,451 (0%) | 0% | 12.2 | 29,118 | Common Stock |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2021 | 31,750 | 31,750 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2021 | 10,820 | 74,828 (0%) | 0% | 0 | Common Stock |